[DOI] [PMC free article] [PubMed] [Google Scholar] 221.Wu L.E., Gomes A.P., Sinclair D.A
Adotvi O, Vernerey D, Jacoulet P, Meurisse A, Laheurte C, Almotlak H, Jacquin M, Kaulek V, Boullerot L et al (2023) Safety, immunogenicity, and 1-year efficacy of universal cancer peptide-based vaccine in patients with refractory advanced non-small-cell lung cancer: a phase Ib/phase IIa de-escalation study
The following day, cells were transfected with 20 nM of siRNA targeting CD36 (sc-29995) from Santa Cruz Biotechnology (Santa Cruz Biotechnology, Dallas, Texas, USA) using Lipofectamine RNAiMAX Reagent from Thermo Fisher Scientific in Opti-MEM media from Gibco accordingly to manufacturers instructions for 48 h, refreshed every day before being treated or not with PA (200 M) during 24 h
120 Subsequently, the preproinsulin is translated at the cytosolic surface of the ER and then translocated into it
The evidence foundation combines mechanistic understanding from molecular studies, efficacy demonstration from clinical trials, safety validation from decades of use, and comprehensive gene expression profiling establishing GHK-Cu as one of the most thoroughly researched regenerative peptides available
